Rapid cellular enrichment of eicosapentaenoate after a single intravenous injection of a novel medium-chain triacylglycerol:fish-oil emulsion in humans
BACKGROUND: Dietary deficiency in n-3 (omega-3) polyunsaturated fatty acids (PUFAs) prevails in Western populations and potentially results in adverse health outcomes. To circumvent the slow n-3 PUFA incorporation in phospholipids of key cells after oral supplementation, a new preparation for intrav...
Saved in:
| Published in | The American journal of clinical nutrition Vol. 91; no. 4; pp. 875 - 882 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Bethesda, MD
American Society for Clinical Nutrition
01.04.2010
American Society for Nutrition American Society for Clinical Nutrition, Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0002-9165 1938-3207 1938-3207 |
| DOI | 10.3945/ajcn.2009.27951 |
Cover
Loading…
| Abstract | BACKGROUND: Dietary deficiency in n-3 (omega-3) polyunsaturated fatty acids (PUFAs) prevails in Western populations and potentially results in adverse health outcomes. To circumvent the slow n-3 PUFA incorporation in phospholipids of key cells after oral supplementation, a new preparation for intravenous bolus injection was developed with 20 g triacylglycerols/100 mL of a mixture of 80% medium-chain triacylglycerols (MCTs) and 20% fish oil (FO) (wt:wt), and 0.4 g α-tocopherol/100 mL of the same mixture. OBJECTIVE: Our objective was to document the enrichment of n-3 PUFAs in leukocyte and platelet phospholipids after a bolus intravenous injection of MCT:FO in men. DESIGN: Twelve healthy male subjects received injections over a 5-min period of 50 mL of either MCT:FO or a control MCT:long-chain triacylglycerol (MCT:LCT) emulsion containing 20 g triacylglycerols/100 mL with equal amounts (wt:wt) of MCT and soybean triacylglycerols (LCT) and containing 0.02 g α-tocopherol/100 mL; after an 8-wk interval, the subjects received injections of the other preparation. RESULTS: Clinical and biological variables that assessed tolerance and safety remained unchanged. Plasma elimination was faster for MCT:FO than for MCT:LCT (half-life: 24.5 ± 3.5 min compared with 32.9 ± 3.0 min; P < 0.025). This was associated with a greater increase in the plasma nonesterified fatty acid concentration. The content of n-3 PUFAs, specifically eicosapentaenoic acid (20:5n-3), increased in leukocyte and platelet phospholipids within 60 min and ≥24 h after MCT:FO injection. CONCLUSION: Bolus intravenous injection of a novel MCT:FO emulsion allows rapid enrichment of cells with n-3 PUFAs. |
|---|---|
| AbstractList | Dietary deficiency in n-3 (omega-3) polyunsaturated fatty acids (PUFAs) prevails in Western populations and potentially results in adverse health outcomes. To circumvent the slow n-3 PUFA incorporation in phospholipids of key cells after oral supplementation, a new preparation for intravenous bolus injection was developed with 20 g triacylglycerols/100 mL of a mixture of 80% medium-chain triacylglycerols (MCTs) and 20% fish oil (FO) (wt:wt), and 0.4 g alpha-tocopherol/100 mL of the same mixture.
Our objective was to document the enrichment of n-3 PUFAs in leukocyte and platelet phospholipids after a bolus intravenous injection of MCT:FO in men.
Twelve healthy male subjects received injections over a 5-min period of 50 mL of either MCT:FO or a control MCT:long-chain triacylglycerol (MCT:LCT) emulsion containing 20 g triacylglycerols/100 mL with equal amounts (wt:wt) of MCT and soybean triacylglycerols (LCT) and containing 0.02 g alpha-tocopherol/100 mL; after an 8-wk interval, the subjects received injections of the other preparation.
Clinical and biological variables that assessed tolerance and safety remained unchanged. Plasma elimination was faster for MCT:FO than for MCT:LCT (half-life: 24.5 +/- 3.5 min compared with 32.9 +/- 3.0 min; P < 0.025). This was associated with a greater increase in the plasma nonesterified fatty acid concentration. The content of n-3 PUFAs, specifically eicosapentaenoic acid (20:5n-3), increased in leukocyte and platelet phospholipids within 60 min and > or =24 h after MCT:FO injection.
Bolus intravenous injection of a novel MCT:FO emulsion allows rapid enrichment of cells with n-3 PUFAs. Background: Dietary deficiency in n−3 (omega-3) polyunsaturated fatty acids (PUFAs) prevails in Western populations and potentially results in adverse health outcomes. To circumvent the slow n−3 PUFA incorporation in phospholipids of key cells after oral supplementation, a new preparation for intravenous bolus injection was developed with 20 g triacylglycerols/100 mL of a mixture of 80% medium-chain triacylglycerols (MCTs) and 20% fish oil (FO) (wt:wt), and 0.4 g α-tocopherol/100 mL of the same mixture. Objective: Our objective was to document the enrichment of n−3 PUFAs in leukocyte and platelet phospholipids after a bolus intravenous injection of MCT:FO in men. Design: Twelve healthy male subjects received injections over a 5-min period of 50 mL of either MCT:FO or a control MCT:long-chain triacylglycerol (MCT:LCT) emulsion containing 20 g triacylglycerols/100 mL with equal amounts (wt:wt) of MCT and soybean triacylglycerols (LCT) and containing 0.02 g α-tocopherol/100 mL; after an 8-wk interval, the subjects received injections of the other preparation. Results: Clinical and biological variables that assessed tolerance and safety remained unchanged. Plasma elimination was faster for MCT:FO than for MCT:LCT (half-life: 24.5 ± 3.5 min compared with 32.9 ± 3.0 min; P < 0.025). This was associated with a greater increase in the plasma nonesterified fatty acid concentration. The content of n−3 PUFAs, specifically eicosapentaenoic acid (20:5n−3), increased in leukocyte and platelet phospholipids within 60 min and ≥24 h after MCT:FO injection. Conclusion: Bolus intravenous injection of a novel MCT:FO emulsion allows rapid enrichment of cells with n−3 PUFAs. Dietary deficiency in n-3 (omega-3) polyunsaturated fatty acids (PUFAs) prevails in Western populations and potentially results in adverse health outcomes. To circumvent the slow n-3 PUFA incorporation in phospholipids of key cells after oral supplementation, a new preparation for intravenous bolus injection was developed with 20 g triacylglycerols/100 mL of a mixture of 80% medium-chain triacylglycerols (MCTs) and 20% fish oil (FO) (wt:wt), and 0.4 g α-tocopherol/100 mL of the same mixture. Our objective was to document the enrichment of n-3 PUFAs in leukocyte and platelet phospholipids after a bolus intravenous injection of MCT:FO in men. Twelve healthy male subjects received injections over a 5-min period of 50 mL of either MCT:FO or a control MCT:long-chain triacylglycerol (MCT:LCT) emulsion containing 20 g triacylglycerols/100 mL with equal amounts (wt:wt) of MCT and soybean triacylglycerols (LCT) and containing 0.02 g α-tocopherol/100 mL; after an 8-wk interval, the subjects received injections of the other preparation. Clinical and biological variables that assessed tolerance and safety remained unchanged. Plasma elimination was faster for MCT:FO than for MCT:LCT (half-life: 24.5 ± 3.5 min compared with 32.9 ± 3.0 min; P < 0.025). This was associated with a greater increase in the plasma nonesterified fatty acid concentration. The content of n-3 PUFAs, specifically eicosapentaenoic acid (20:5n-3), increased in leukocyte and platelet phospholipids within 60 min and ≥24 h after MCT:FO injection. Bolus intravenous injection of a novel MCT:FO emulsion allows rapid enrichment of cells with n-3 PUFAs. BACKGROUND: Dietary deficiency in n-3 (omega-3) polyunsaturated fatty acids (PUFAs) prevails in Western populations and potentially results in adverse health outcomes. To circumvent the slow n-3 PUFA incorporation in phospholipids of key cells after oral supplementation, a new preparation for intravenous bolus injection was developed with 20 g triacylglycerols/100 mL of a mixture of 80% medium-chain triacylglycerols (MCTs) and 20% fish oil (FO) (wt:wt), and 0.4 g α-tocopherol/100 mL of the same mixture. OBJECTIVE: Our objective was to document the enrichment of n-3 PUFAs in leukocyte and platelet phospholipids after a bolus intravenous injection of MCT:FO in men. DESIGN: Twelve healthy male subjects received injections over a 5-min period of 50 mL of either MCT:FO or a control MCT:long-chain triacylglycerol (MCT:LCT) emulsion containing 20 g triacylglycerols/100 mL with equal amounts (wt:wt) of MCT and soybean triacylglycerols (LCT) and containing 0.02 g α-tocopherol/100 mL; after an 8-wk interval, the subjects received injections of the other preparation. RESULTS: Clinical and biological variables that assessed tolerance and safety remained unchanged. Plasma elimination was faster for MCT:FO than for MCT:LCT (half-life: 24.5 ± 3.5 min compared with 32.9 ± 3.0 min; P < 0.025). This was associated with a greater increase in the plasma nonesterified fatty acid concentration. The content of n-3 PUFAs, specifically eicosapentaenoic acid (20:5n-3), increased in leukocyte and platelet phospholipids within 60 min and ≥24 h after MCT:FO injection. CONCLUSION: Bolus intravenous injection of a novel MCT:FO emulsion allows rapid enrichment of cells with n-3 PUFAs. Dietary deficiency in n-3 (omega-3) polyunsaturated fatty acids (PUFAs) prevails in Western populations and potentially results in adverse health outcomes. To circumvent the slow n-3 PUFA incorporation in phospholipids of key cells after oral supplementation, a new preparation for intravenous bolus injection was developed with 20 g triacylglycerols/100 mL of a mixture of 80% medium-chain triacylglycerols (MCTs) and 20% fish oil (FO) (wt:wt), and 0.4 g alpha-tocopherol/100 mL of the same mixture.BACKGROUNDDietary deficiency in n-3 (omega-3) polyunsaturated fatty acids (PUFAs) prevails in Western populations and potentially results in adverse health outcomes. To circumvent the slow n-3 PUFA incorporation in phospholipids of key cells after oral supplementation, a new preparation for intravenous bolus injection was developed with 20 g triacylglycerols/100 mL of a mixture of 80% medium-chain triacylglycerols (MCTs) and 20% fish oil (FO) (wt:wt), and 0.4 g alpha-tocopherol/100 mL of the same mixture.Our objective was to document the enrichment of n-3 PUFAs in leukocyte and platelet phospholipids after a bolus intravenous injection of MCT:FO in men.OBJECTIVEOur objective was to document the enrichment of n-3 PUFAs in leukocyte and platelet phospholipids after a bolus intravenous injection of MCT:FO in men.Twelve healthy male subjects received injections over a 5-min period of 50 mL of either MCT:FO or a control MCT:long-chain triacylglycerol (MCT:LCT) emulsion containing 20 g triacylglycerols/100 mL with equal amounts (wt:wt) of MCT and soybean triacylglycerols (LCT) and containing 0.02 g alpha-tocopherol/100 mL; after an 8-wk interval, the subjects received injections of the other preparation.DESIGNTwelve healthy male subjects received injections over a 5-min period of 50 mL of either MCT:FO or a control MCT:long-chain triacylglycerol (MCT:LCT) emulsion containing 20 g triacylglycerols/100 mL with equal amounts (wt:wt) of MCT and soybean triacylglycerols (LCT) and containing 0.02 g alpha-tocopherol/100 mL; after an 8-wk interval, the subjects received injections of the other preparation.Clinical and biological variables that assessed tolerance and safety remained unchanged. Plasma elimination was faster for MCT:FO than for MCT:LCT (half-life: 24.5 +/- 3.5 min compared with 32.9 +/- 3.0 min; P < 0.025). This was associated with a greater increase in the plasma nonesterified fatty acid concentration. The content of n-3 PUFAs, specifically eicosapentaenoic acid (20:5n-3), increased in leukocyte and platelet phospholipids within 60 min and > or =24 h after MCT:FO injection.RESULTSClinical and biological variables that assessed tolerance and safety remained unchanged. Plasma elimination was faster for MCT:FO than for MCT:LCT (half-life: 24.5 +/- 3.5 min compared with 32.9 +/- 3.0 min; P < 0.025). This was associated with a greater increase in the plasma nonesterified fatty acid concentration. The content of n-3 PUFAs, specifically eicosapentaenoic acid (20:5n-3), increased in leukocyte and platelet phospholipids within 60 min and > or =24 h after MCT:FO injection.Bolus intravenous injection of a novel MCT:FO emulsion allows rapid enrichment of cells with n-3 PUFAs.CONCLUSIONBolus intravenous injection of a novel MCT:FO emulsion allows rapid enrichment of cells with n-3 PUFAs. |
| Author | Carpentier, Yvon A Hacquebard, Mirjam Dupont, Isabelle E Malaisse, Willy J Deckelbaum, Richard J Portois, Laurence |
| Author_xml | – sequence: 1 fullname: Carpentier, Yvon A – sequence: 2 fullname: Hacquebard, Mirjam – sequence: 3 fullname: Portois, Laurence – sequence: 4 fullname: Dupont, Isabelle E – sequence: 5 fullname: Deckelbaum, Richard J – sequence: 6 fullname: Malaisse, Willy J |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22607162$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20147473$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktvEzEUhUeoiKaFNTuwkAqrSf0ae4YFEqp4SZWQgK6tG8dOHHnsYM9Eyi_h79ZDQoEuurItf-fq3HPvWXUSYjBV9ZzgOet4cwkbHeYU425OZdeQR9WMdKytGcXypJphjGndEdGcVmc5bzAmlLfiSXVKMeGSSzarfn2DrVsibbwfPSRkQnJ63ZswoGiRcTpm2JYXmBBhMAjsYBIClF1YeYNcGBLsyt-Yy31j9OBimJSAQtwZj3qzdGNf6zW4gIbkQO_9yu-1SdG_tS6v6-g8Mv3o86Qs0HrsIeSn1WMLPptnx_O8uvn44cfV5_r666cvV--va93QbqiJZkvJpBWMCMG0EK22UkqhmaUtaw3j0hK9WBohdMc40dwseIdhqUXTMrJg59W7Q93tuChetZka8mqbXA9pryI49f9PcGu1ijtFW86FbEqBN8cCKf4cTR5U7_IUJwRTUlGSsaalTUMK-fpBkhdLnLWygK_ugZs4plBiUJSV-ZYGRIFe_Gv8zvGf0Rbg4ghA1uBtgqBd_stRgSURtHCXB06nmHMy9g4hWE1LpqYlU9OSqd9LVhTNPYV2A0yTLwk5_4Du5UFnISpYpeLm5nvxyzBpp_FRdgsIr-MV |
| CODEN | AJCNAC |
| CitedBy_id | crossref_primary_10_1016_j_jevs_2012_12_008 crossref_primary_10_1177_0148607113505326 crossref_primary_10_1016_j_tvjl_2014_10_021 crossref_primary_10_1146_annurev_nutr_082018_124539 crossref_primary_10_1177_0148607114560825 crossref_primary_10_1177_0884533616662996 crossref_primary_10_1002_jpen_2041 crossref_primary_10_1177_0884533610393255 crossref_primary_10_1016_j_toxrep_2014_10_011 crossref_primary_10_1096_fj_202300396R crossref_primary_10_1097_MCO_0000000000000249 crossref_primary_10_1016_j_clnu_2020_07_002 crossref_primary_10_1016_j_clnu_2014_07_005 crossref_primary_10_1017_jns_2024_11 crossref_primary_10_1177_0148607112439211 crossref_primary_10_1016_j_tiv_2015_07_004 crossref_primary_10_1186_s13054_022_03896_3 crossref_primary_10_1002_cnr2_70025 crossref_primary_10_1016_j_clnu_2016_06_001 crossref_primary_10_1371_journal_pone_0049510 crossref_primary_10_3390_metabo14010019 crossref_primary_10_1016_j_biopha_2024_116749 crossref_primary_10_1111_j_1365_2362_2011_02582_x crossref_primary_10_3164_jcbn_13_90 crossref_primary_10_1093_ajcn_nqz281 crossref_primary_10_1097_CCE_0000000000000977 crossref_primary_10_1093_ajcn_nqy370 crossref_primary_10_3390_medicina58070885 crossref_primary_10_1177_03000605211011805 crossref_primary_10_3390_antibiotics7010022 crossref_primary_10_1177_0148607113493326 crossref_primary_10_3164_jcbn_12_86 crossref_primary_10_1007_s11894_011_0203_y crossref_primary_10_1177_0148607114568670 crossref_primary_10_3945_ajcn_112_046573 |
| Cites_doi | 10.1177/0148607197021004224 10.1056/NEJM200001203420302 10.1016/S0022-2275(20)40587-5 10.1016/S0076-6879(94)33049-2 10.1016/S0140-6736(99)07072-5 10.1161/01.CIR.0000038493.65177.94 10.1093/ajcn.81.2.341 10.1161/01.CIR.99.18.2452 10.1152/ajpendo.2001.280.4.E576 10.4049/jimmunol.171.9.4837 10.1016/S0140-6736(00)02783-5 10.1016/S0140-6736(96)90866-1 10.1161/01.CIR.102.18.2284 10.1093/ajcn/61.1.56 10.1161/01.CIR.0000152099.87287.83 10.1093/ajcn/84.1.5 10.1007/978-1-4757-4448-4_1 10.1079/PNS2003252 10.1016/S0140-6736(04)16105-9 10.1016/0261-5614(92)90002-8 10.1021/bi00182a015 |
| ContentType | Journal Article |
| Copyright | 2015 INIST-CNRS Copyright American Society for Clinical Nutrition, Inc. Apr 1, 2010 2010 American Society for Nutrition 2010 |
| Copyright_xml | – notice: 2015 INIST-CNRS – notice: Copyright American Society for Clinical Nutrition, Inc. Apr 1, 2010 – notice: 2010 American Society for Nutrition 2010 |
| DBID | FBQ AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7T7 7TS 8FD C1K FR3 K9. NAPCQ P64 7S9 L.6 7X8 5PM |
| DOI | 10.3945/ajcn.2009.27951 |
| DatabaseName | AGRIS CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Physical Education Index Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Technology Research Database ProQuest Health & Medical Complete (Alumni) Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Calcium & Calcified Tissue Abstracts Physical Education Index Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Nursing & Allied Health Premium MEDLINE - Academic AGRICOLA |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Diet & Clinical Nutrition |
| EISSN | 1938-3207 |
| EndPage | 882 |
| ExternalDocumentID | PMC2844675 1990527911 20147473 22607162 10_3945_ajcn_2009_27951 US201301816632 |
| Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: HL-40404 |
| GroupedDBID | --- -ET -~X ..I .55 .GJ 0R~ 1HT 23M 2FS 2WC 3O- 4.4 48X 53G 5GY 5RE 5VS 6J9 85S 8R4 8R5 AABZA AACZT AAGQS AAHBH AAIKC AAJQQ AAMNW AAPGJ AAPQZ AAUQX AAUTI AAVAP AAWDT AAWTL AAXUO AAYOK ABBTP ABDNZ ABDPE ABIME ABJNI ABLJU ABOCM ABPTD ABWST ACFRR ACGFO ACGFS ACGOD ACNCT ACPRK ACPVT ACUFI ACUTJ ADBBV ADGZP ADHUB ADMTO ADRTK ADUKH ADVEK ADVLN AEGXH AENEX AETBJ AFFDN AFFNX AFFZL AFJKZ AFOFC AFRAH AFXAL AGINJ AGKRT AGNAY AGQXC AGUTN AHMBA AI. AIAGR AITUG AJEEA AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ ANFBD AQDSO AQKUS BAWUL BAYMD BKOMP BTRTY C1A CDBKE DAKXR DIK E3Z EBS EIHJH EJD ENERS EX3 F5P F9R FBQ FDB FECEO FLUFQ FOEOM FOTVD FQBLK FRP GAUVT GJXCC GX1 H13 HF~ HZ~ IH2 J5H KBUDW KOP KQ8 KSI KSN L7B LPU MBLQV MHKGH MV1 MVM N4W NEJ NHB NHCRO NOMLY NOYVH NVLIB O9- ODMLO OHT OK1 OVD P2P P6G PCD PQQKQ PRG Q2X R0Z RHI RNS ROL SJN TCN TEORI TMA TNT TR2 TWZ UBH UHB UKR VH1 W2D W8F WH7 WHG WOQ WOW X7M XOL XSW YBU YHG YOJ YQJ YR5 YRY YSK YV5 YYQ YZZ ZCA ZCG ZGI ZUP ZXP ~KM AALRI AAYWO AAYXX ACVFH ADCNI AEUPX AFPUW AGCQF AIGII AKBMS AKYEP APXCP CITATION NU- EFKBS IQODW A8Z ABSAR BCRHZ CGR CUY CVF ECM EIF NPM RHF ROX SV3 VXZ Z5M 7QP 7T7 7TS 8FD C1K FR3 K9. NAPCQ P64 7S9 L.6 7X8 5PM |
| ID | FETCH-LOGICAL-c529t-1c3d737f631663c668cf7776c3f2838e347f1cbde66c9341c4eb490adc65831b3 |
| ISSN | 0002-9165 1938-3207 |
| IngestDate | Thu Aug 21 18:09:23 EDT 2025 Fri Sep 05 09:22:00 EDT 2025 Thu Sep 04 19:33:24 EDT 2025 Fri Jul 25 05:50:34 EDT 2025 Wed Feb 19 02:24:39 EST 2025 Mon Jul 21 09:13:26 EDT 2025 Tue Jul 01 04:02:50 EDT 2025 Thu Apr 24 23:07:41 EDT 2025 Thu Apr 03 09:42:22 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Enrichment Human Emulsion Intravenous administration Triacylglycerol Single dose Medium chain Fish oil |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c529t-1c3d737f631663c668cf7776c3f2838e347f1cbde66c9341c4eb490adc65831b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 Supported by grant RBC-BR 246/2410 from the Région de Bruxelles-Capitale (Brussels, Belgium) to Target Hit sa (Brussels, Belgium); YAC, LP, IED, and WJM were also affiliated with Target Hit sa. Also supported by grant HL-40404 from the National Institutes of Health to RJD and by B Braun Melsungen AG (Melsungen, Germany). Emulsions were provided by B Braun Melsungen AG. |
| PMID | 20147473 |
| PQID | 231934906 |
| PQPubID | 41076 |
| PageCount | 8 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2844675 proquest_miscellaneous_733582551 proquest_miscellaneous_46584387 proquest_journals_231934906 pubmed_primary_20147473 pascalfrancis_primary_22607162 crossref_primary_10_3945_ajcn_2009_27951 crossref_citationtrail_10_3945_ajcn_2009_27951 fao_agris_US201301816632 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2010-04-01 |
| PublicationDateYYYYMMDD | 2010-04-01 |
| PublicationDate_xml | – month: 04 year: 2010 text: 2010-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Bethesda, MD |
| PublicationPlace_xml | – name: Bethesda, MD – name: United States – name: Bethesda |
| PublicationTitle | The American journal of clinical nutrition |
| PublicationTitleAlternate | Am J Clin Nutr |
| PublicationYear | 2010 |
| Publisher | American Society for Clinical Nutrition American Society for Nutrition American Society for Clinical Nutrition, Inc |
| Publisher_xml | – name: American Society for Clinical Nutrition – name: American Society for Nutrition – name: American Society for Clinical Nutrition, Inc |
| References | Wang (10.3945/ajcn.2009.27951_bib7) 2006; 84 Mozaffarian (10.3945/ajcn.2009.27951_bib2) 2005; 111 Carpentier (10.3945/ajcn.2009.27951_bib13) 2006; 18 (10.3945/ajcn.2009.27951_bib8) 1999; 354 Christensen (10.3945/ajcn.2009.27951_bib9) 1995; 61 Billman (10.3945/ajcn.2009.27951_bib11) 1999; 99 Pradier (10.3945/ajcn.2009.27951_bib18) 2008; 22 Schrepf (10.3945/ajcn.2009.27951_bib12) 2004; 363 10.3945/ajcn.2009.27951_bib4 Peltier (10.3945/ajcn.2009.27951_bib22) 2006; 18 Boaz (10.3945/ajcn.2009.27951_bib24) 2000; 356 Dahlan (10.3945/ajcn.2009.27951_bib14) 1992; 11 Puhl (10.3945/ajcn.2009.27951_bib16) 1994; 233 Cordain (10.3945/ajcn.2009.27951_bib5) 2005; 81 Fontaine (10.3945/ajcn.2009.27951_bib21) 2006; 18 Krauss (10.3945/ajcn.2009.27951_bib3) 2000; 102 Yusuf (10.3945/ajcn.2009.27951_bib25) 2000; 342 Richelle (10.3945/ajcn.2009.27951_bib19) 1994; 33 Kris-Etherton (10.3945/ajcn.2009.27951_bib1) 2002; 106 Hatam (10.3945/ajcn.2009.27951_bib15) 1979; 20 Browning (10.3945/ajcn.2009.27951_bib6) 2003; 62 Stephens (10.3945/ajcn.2009.27951_bib23) 1996; 347 Soop (10.3945/ajcn.2009.27951_bib17) 2001; 280 Mayer (10.3945/ajcn.2009.27951_bib20) 2003; 171 Oliveira (10.3945/ajcn.2009.27951_bib10) 1997; 21 |
| References_xml | – volume: 21 start-page: 224 year: 1997 ident: 10.3945/ajcn.2009.27951_bib10 article-title: Triglyceride hydrolysis of soy oil vs fish oil emulsions publication-title: JPEN J Parenter Enteral Nutr doi: 10.1177/0148607197021004224 – volume: 342 start-page: 154 year: 2000 ident: 10.3945/ajcn.2009.27951_bib25 article-title: Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators publication-title: N Engl J Med doi: 10.1056/NEJM200001203420302 – volume: 20 start-page: 639 year: 1979 ident: 10.3945/ajcn.2009.27951_bib15 article-title: A high-performance liquid chromatographic method for the determination of tocopherol in plasma and cellular elements of the blood publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)40587-5 – volume: 233 start-page: 425 year: 1994 ident: 10.3945/ajcn.2009.27951_bib16 article-title: Methods to determine oxidation of low-density lipoproteins publication-title: Methods Enzymol doi: 10.1016/S0076-6879(94)33049-2 – volume: 354 start-page: 447 year: 1999 ident: 10.3945/ajcn.2009.27951_bib8 article-title: Dietary supplementation with n−3 polyunsaturated PUFAs and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial publication-title: Lancet doi: 10.1016/S0140-6736(99)07072-5 – volume: 106 start-page: 2747 year: 2002 ident: 10.3945/ajcn.2009.27951_bib1 article-title: American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease publication-title: Circulation doi: 10.1161/01.CIR.0000038493.65177.94 – volume: 81 start-page: 341 year: 2005 ident: 10.3945/ajcn.2009.27951_bib5 article-title: Origins and evolution of the Western diet: health implications for the 21st century publication-title: Am J Clin Nutr doi: 10.1093/ajcn.81.2.341 – volume: 18 start-page: 741 year: 2006 ident: 10.3945/ajcn.2009.27951_bib22 article-title: Acute in vivo administration of a fish oil-containing emulsion improves post-ischemic cardiac function in n-3-depleted rats publication-title: Int J Mol Med – volume: 99 start-page: 2452 year: 1999 ident: 10.3945/ajcn.2009.27951_bib11 article-title: Prevention of sudden cardiac death by dietary pure ω-3 polyunsaturated fatty acids in dogs publication-title: Circulation doi: 10.1161/01.CIR.99.18.2452 – volume: 18 start-page: 697 year: 2006 ident: 10.3945/ajcn.2009.27951_bib21 article-title: Protection of aortic endothelial function in both normal and diabetic rats by intravenous bolus injection of a medium-chain triglyceride: fish oil emulsion publication-title: Int J Mol Med – volume: 280 start-page: E576 year: 2001 ident: 10.3945/ajcn.2009.27951_bib17 article-title: Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.2001.280.4.E576 – volume: 171 start-page: 4837 year: 2003 ident: 10.3945/ajcn.2009.27951_bib20 article-title: Short-time infusion of fish-oil based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans publication-title: J Immunol doi: 10.4049/jimmunol.171.9.4837 – volume: 356 start-page: 1213 year: 2000 ident: 10.3945/ajcn.2009.27951_bib24 article-title: Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE):randomised placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(00)02783-5 – volume: 347 start-page: 781 year: 1996 ident: 10.3945/ajcn.2009.27951_bib23 article-title: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) publication-title: Lancet doi: 10.1016/S0140-6736(96)90866-1 – volume: 102 start-page: 2284 year: 2000 ident: 10.3945/ajcn.2009.27951_bib3 article-title: AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association publication-title: Circulation doi: 10.1161/01.CIR.102.18.2284 – volume: 61 start-page: 56 year: 1995 ident: 10.3945/ajcn.2009.27951_bib9 article-title: Intestinal absorption and lymphatic transport of eicosapentaenoic (EPA), docosahexaenoic (DHA), and decanoic acids: dependence on intramolecular triacylglycerol structure publication-title: Am J Clin Nutr doi: 10.1093/ajcn/61.1.56 – volume: 111 start-page: 157 year: 2005 ident: 10.3945/ajcn.2009.27951_bib2 article-title: Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men publication-title: Circulation doi: 10.1161/01.CIR.0000152099.87287.83 – volume: 84 start-page: 5 year: 2006 ident: 10.3945/ajcn.2009.27951_bib7 article-title: n−3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review publication-title: Am J Clin Nutr doi: 10.1093/ajcn/84.1.5 – volume: 18 start-page: 1177 year: 2006 ident: 10.3945/ajcn.2009.27951_bib13 article-title: Preclinical investigations of a medium-chain triglyceride:fish oil emulsion. III. Experiments in cultured endothelial cells publication-title: Int J Mol Med – ident: 10.3945/ajcn.2009.27951_bib4 doi: 10.1007/978-1-4757-4448-4_1 – volume: 62 start-page: 447 year: 2003 ident: 10.3945/ajcn.2009.27951_bib6 article-title: n−3 Polyunsaturated fatty acids, inflammation and obesity-related disease publication-title: Proc Nutr Soc doi: 10.1079/PNS2003252 – volume: 363 start-page: 1441 year: 2004 ident: 10.3945/ajcn.2009.27951_bib12 article-title: Immediate effects of n−3 fatty acid infusion on the induction of sustained ventricular tachycardia publication-title: Lancet doi: 10.1016/S0140-6736(04)16105-9 – volume: 11 start-page: 262 year: 1992 ident: 10.3945/ajcn.2009.27951_bib14 article-title: Effects of essential fatty acid contents of lipid emulsions on erythrocyte polyunsaturated fatty acid composition in patients on long-term parenteral nutrition publication-title: Clin Nutr doi: 10.1016/0261-5614(92)90002-8 – volume: 22 start-page: 301 year: 2008 ident: 10.3945/ajcn.2009.27951_bib18 article-title: Hemostatic safety of the bolus intravenous injection of a novel medium-chain triglyceride:fish oil emulsion publication-title: Int J Mol Med – volume: 33 start-page: 4872 year: 1994 ident: 10.3945/ajcn.2009.27951_bib19 article-title: Long- and medium-chain triacylglycerols in neutral lipid-exchange processes with human plasma low-density lipoproteins publication-title: Biochemistry doi: 10.1021/bi00182a015 |
| SSID | ssj0012486 |
| Score | 2.1709545 |
| Snippet | BACKGROUND: Dietary deficiency in n-3 (omega-3) polyunsaturated fatty acids (PUFAs) prevails in Western populations and potentially results in adverse health... Dietary deficiency in n-3 (omega-3) polyunsaturated fatty acids (PUFAs) prevails in Western populations and potentially results in adverse health outcomes. To... Background: Dietary deficiency in n−3 (omega-3) polyunsaturated fatty acids (PUFAs) prevails in Western populations and potentially results in adverse health... |
| SourceID | pubmedcentral proquest pubmed pascalfrancis crossref fao |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 875 |
| SubjectTerms | administration & dosage Adult adults adverse effects alpha-tocopherol alpha-Tocopherol - administration & dosage Biological and medical sciences blood blood platelets Blood Platelets - drug effects Blood Platelets - metabolism Cross-Over Studies deficiency Dietary Fats Dietary Fats - administration & dosage dosage Double-Blind Method drug effects eicosapentaenoic acid Eicosapentaenoic Acid - blood Fat Emulsions, Intravenous Fatty acids Fatty Acids, Essential Fatty Acids, Essential - deficiency Fatty Acids, Nonesterified Fatty Acids, Nonesterified - blood Feeding. Feeding behavior Fish oils Fish Oils - administration & dosage Fish Oils - blood Fish Oils - pharmacology free fatty acids Fundamental and applied biological sciences. Psychology Humans Injections Injections, Intravenous intravenous injection leukocytes Leukocytes - drug effects Leukocytes - metabolism Lipids Male medium chain fatty acids men metabolism Nutrition omega-3 fatty acids oral administration Original Research Communications pharmacokinetics pharmacology phospholipids Phospholipids - metabolism Plasma polyunsaturated fatty acids triacylglycerols Triglycerides Triglycerides - administration & dosage Triglycerides - blood Triglycerides - pharmacology Vertebrates: anatomy and physiology, studies on body, several organs or systems |
| Title | Rapid cellular enrichment of eicosapentaenoate after a single intravenous injection of a novel medium-chain triacylglycerol:fish-oil emulsion in humans |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/20147473 https://www.proquest.com/docview/231934906 https://www.proquest.com/docview/46584387 https://www.proquest.com/docview/733582551 https://pubmed.ncbi.nlm.nih.gov/PMC2844675 |
| Volume | 91 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwELV6kRAvCMqloVD8gBDSKmUTZ-OEt4qCClX7UFpRniLHcbqpsslqs1up_Ai_w6cxEzuXXVoJeIlWG8dxdE7smXjmDCGvGUviJE49m4sAHBQpHTtQaWAzsMV5Go5kXCfSHp_4h-fel4vRxdrar17U0mIe78kft-aV_A-q8B_gilmy_4Bs2yn8Ab8BXzgCwnD8K4xPxTRLBvjtvQ4mhWaZHDe7-wowrsQUY8NVUYJJaeqBiwF-HshRLGSOtYdqjdasuFKyMR7FoCivlc4qWUxsORYYDAnPI2_yy_xGqlmZwxDTrBrbZZYP1GSRVyZmsq75V_VN3rMud6XoC1W0OZlFUxCg2w-Z4bAzzabv19DzfjdTSljJYqEj8o-z2ZWYtNM7uBKl1kzAdG_V4_PBYlpqhYXPlcC9FmVSMMwHD9yrb-NklJ6kQ5ikmaur5TazuK75Zdjq9abkQFdmWV0qWOihqoa4koVWLXV5qKVve8SZTmrmwCg8cLtYt2a2kYzNqXWy6YKjMtwgm_tHp9-O2p0s1wt8LSmFd3y3cj_UojY9LBlG66koMUxXVIBDqkus3OYDrYby9myjs4fkgXFq6L5m6COypootYh1kak7fUKM8m9OTBuctcu_YhHQ8Jj9rEtOGxLQjMS1T-geJaU1iKqgmMe2RmLYkxisFrUlM-ySmKyR-31CYNhSGPqim8BNy_unj2YdD21QLseXIDee2I1nCGU995oAVLX0_kCnn3JcsBRM6UMzjqSPjRPm-DMF2k56KvXAoEglGOHNi9pRsFGWhtgn1oANM8A7RX1dChUno-2rkcA7rVRx7FtlroIqkkdLHii55BC41whwhzFjhNYxqmC3ytr1gqlVk7m66DdhH4hLW-Oj8q4uRBQ5u7jPXIrtLhGi7AhdqiEpwFtlpGBKZ97mKwIGDxw2HvkVetWdhDUFcRaEAnshDN4QF3CL0jhacYUb9CIf3TBOuu7nhr0X4EhXbBihgv3ymyMa1kD2YxmCnjZ7f2ecOud_NAC_Ixny2UC_BCZjHu-Y9-w0q_xDx |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rapid+cellular+enrichment+of+eicosapentaenoate+after+a+single+intravenous+injection+of+a+novel+medium-chain+triacylglycerol%3Afish-oil+emulsion+in+humans&rft.jtitle=The+American+journal+of+clinical+nutrition&rft.au=Carpentier%2C+Yvon+A&rft.au=Hacquebard%2C+Mirjam&rft.au=Portois%2C+Laurence&rft.au=Dupont%2C+Isabelle+E&rft.date=2010-04-01&rft.eissn=1938-3207&rft.volume=91&rft.issue=4&rft.spage=875&rft_id=info:doi/10.3945%2Fajcn.2009.27951&rft_id=info%3Apmid%2F20147473&rft.externalDocID=20147473 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9165&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9165&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9165&client=summon |